How pharmacist Integration Can Enhance Dermatology Care and Patient Outcomes
Dermatological conditions such as atopic dermatitis (AD), psoriasis, and hidradenitis suppurativa (HS) can pose significant challenges, especially when it comes to accessing and adhering to specialty medications. These chronic inflammatory skin conditions often require specific treatments to manage symptoms and prevent flare-ups. However, high costs and limited medication availability can lead to delayed treatment, negatively impacting patients’ quality of life.
Doctor dermatologist examines skin of patient. Dermatoscopy, prevention of melanoma, skin cancer – Image credit: InsideCreativeHouse | stock.adobe.com
To tackle these issues, many health systems are turning to integrated specialty pharmacies and embedded pharmacists in clinics. By incorporating pharmacists directly into dermatology practices, health providers aim to enhance medication management and improve overall patient outcomes.
Embedding Pharmacists in Dermatology Clinics
In a recent study, researchers from the University of Louisville (UofL) Health evaluated the impact of embedding a pharmacist in their dermatology clinic. The study, which took place from October 2019 to October 2021, involved a postgraduate year 2 (PGY-2) ambulatory care pharmacy resident working part-time in the clinic. The pharmacist focused on medication selection, initiation, access, education, and monitoring, aiming to address challenges related to specialty medication access and adherence.
Study Methodology and Outcomes
The study compared patients treated before and after the pharmacist’s integration. Researchers analyzed various outcomes, including prescription volume, time to medication initiation, medication adherence, adverse events, quality of life changes, pharmacist interventions, and patient satisfaction.
A total of 27 patients were included in the post-intervention group and 21 in the pre-intervention group. Most had Medicaid or Medicare insurance and were diagnosed with psoriasis, AD, or HS. Adalimumab (Humira) and dupilumab (Dupixent) were the most commonly prescribed medications.
The study revealed a significant 28.87% increase in prescription volume in the post-intervention group. Time to medication initiation reduced, although the difference was not statistically significant. Adherence rates were high in both groups, with the post-intervention group showing slightly lower adherence.
Pharmacist interventions, such as recommending lab monitoring and dose adjustments, were provided to 25.9% of the post-intervention group, compared to 19% of the pre-intervention group. Patient satisfaction remained high in both groups, indicating a positive overall experience.
Positive Financial and Clinical Impact
The increased prescription volume translated to higher revenue, which the researchers suggested could justify additional investment in a full-time pharmacist position. This model demonstrates a positive return on investment (ROI), highlighting the potential for enhancing dermatology services through pharmacist integration.
The embedding of pharmacists in dermatology clinics not only improved the relationship between providers and specialty pharmacies but also had a positive impact on clinical outcomes. This approach underscores the critical role pharmacists play in dermatology care, contributing to better patient quality of life.
Conclusion
The findings of the UofL Health study provide compelling evidence of the benefits of integrating pharmacists into dermatology clinics. By addressing medication access and adherence challenges, this approach can lead to improved patient outcomes and enhanced quality of life. As healthcare systems continue to explore ways to improve specialty medication management, pharmacist integration appears to be a promising strategy.
If you found this article informative, we invite you to share your thoughts and experiences in the comments below. Don’t forget to subscribe to our newsletter for more insights and updates on dermatology and healthcare innovations.
